Management

Josh Mandel-Brehm

President & Chief Executive Officer

David Bumcrot, PhD

Senior Vice President, Head of Biology

Kelly Gold

Vice President of Corporate Development & Finance

Iris Grossman, PhD

Chief Scientific Officer

Caleb Moore

Vice President, Portfolio Strategy & Business Operations

Tali Ronen

Head of People

Asher Schachter, MD

Senior Vice President, Clinical
Head of Pharmaceutical Sciences

Board of Directors

Chair
Steven Holtzman, Chairman

President & CEO, Decibel Therapeutics

Josh Mandel-Brehm

President & CEO, CAMP4 Therapeutics

Jorge Conde

General Partner, Andreessen Horowitz

Michael Higgins

CEO, Kindex Pharmaceuticals

Amir Nashat, ScD

Managing Partner, Polaris Partners

Paula Ragan, PhD

President & CEO, X4 Pharmaceuticals

Richard Young, PhD

Member, Whitehead Institute
Professor of Biology, MIT

Founders

Richard Young, PhD

Member, Whitehead Institute
Professor of Biology, MIT

Leonard Zon, MD

Grousbeck Professor of Pediatric Medicine, Harvard Medical School
Investigator, Howard Hughes Medical Institute
Director, Stem Cell Program, Boston Children’s Hospital

Business Advisors

Ken DiPietro

Chief Human Resources Officer, Cerevel Therapeutics

Peter Hecht, PhD

CEO, Cyclerion Therapeutics

Doug Williams, PhD

CEO, Codiak Biosciences

Scientific Advisory Board

Chair
Michael Hayden, CM OB CMB ChB PhD FRCP(C) FRSC

University of British Columbia

Jason Buenrostro, PhD

Broad Institute, Harvard University

Felix Frueh, PhD

Opus Three

Wolfram Goessling, MD, PhD

Harvard Medical School/Massachusetts General Hospital/Brigham & Women’s Hospital

Joel Hirschhorn, MD, PhD

Harvard Medical School/Boston Children’s Hospital

Rudolf Jaenisch, MD

Whitehead Institute, Massachusetts Institute of Technology

Benjamin Neale, PhD

Massachusetts General Hospital, Broad Institute

Jay Shendure, MD, PhD

University of Washington
Top